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Objectives—Previous studies have shown that residential proximity to a roadway is associated with increased cardiovascular
disease risk. Yet, the nature of this association remains unclear, and its effect on individual cardiovascular disease risk
factors has not been assessed. The objective of this study was to determine whether residential proximity to roadways
influences systemic inflammation and the levels of circulating angiogenic cells.
Approach and Results—In a cross-sectional study, cardiovascular disease risk factors, blood levels of C-reactive protein, and
15 antigenically defined circulating angiogenic cell populations were measured in participants (n=316) with moderate-tohigh cardiovascular disease risk. Attributes of roadways surrounding residential locations were assessed using geographic
information systems. Associations between road proximity and cardiovascular indices were analyzed using generalized
linear models. Close proximity (<50 m) to a major roadway was associated with lower income and higher rates of
smoking but not C-reactive protein levels. After adjustment for potential confounders, the levels of circulating angiogenic
cells in peripheral blood were significantly elevated in people living in close proximity to a major roadway (CD31+/
AC133+, AC133+, CD34+/AC133+, and CD34+/45dim/AC133+ cells) and positively associated with road segment distance
(CD31+/AC133+, AC133+, and CD34+/AC133+ cells), traffic intensity (CD31+/AC133+ and AC133+ cells), and distanceweighted traffic intensity (CD31+/34+/45+/AC133+ cells).
Conclusions—Living close to a major roadway is associated with elevated levels of circulating cells positive for the early
stem marker AC133+. This may reflect an increased need for vascular repair. Levels of these cells in peripheral blood may
be a sensitive index of cardiovascular injury because of residential proximity to roadways.   (Arterioscler Thromb Vasc
Biol. 2015;35:2468-2477. DOI: 10.1161/ATVBAHA.115.305724.)
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S

that contribute to cardiovascular risk and injury have not been
identified with certainty, cardiovascular injury has been found
to be most closely associated with the levels of fine particulate matter with an aerodynamic diameter ≤2.5 μm (PM2.5) in
the ambient air.3,5 Specific source apportionment studies suggest that the cardiovascular effects of ambient air pollutants

everal studies suggest that exposure to environmental
pollutants increases the risk of developing cardiovascular disease (CVD).1,2 Chronic exposure to polluted environments is associated with metabolic and inflammatory changes,
increased progression of subclinical measures of CVD, and
acceleration of atherogenesis.3 Acute exposure to high levels
of ambient pollutants has also been linked to the precipitation
of acute cardiovascular events.4 Although specific pollutants
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could be linked to the pollutants generated by both stationary
and mobile sources.6,7 In most urban environments, mobile
sources, such as gasoline and diesel engine exhaust, contribute to a significant portion of ambient air particles and volatile
organic compounds.8,9
The concept that chronic exposure to traffic-generated pollutants could contribute to CVD is supported by epidemiological studies, showing that living in close proximity to a major
roadway is associated with increased CVD risk and CVD
mortality. Close proximity to roadways has been associated
with increased coronary artery disease mortality,10–12 myocardial infarction,13,14 heart failure,15 deep vein thrombosis,16
and stroke mortality.17 C-reactive protein, a clinical CVD risk
indicator and marker of inflammation, has also been positively
associated with traffic density.18 In addition, inverse associations have been identified between roadway proximity and
subclinical risk predictors, including coronary artery calcification19 and oxidized low-density lipoprotein.20 Nevertheless,
the mechanisms by which residential proximity to roadways
increases CVD risk remain unclear.
This study was designed to investigate how residential
proximity to roadways affects systemic inflammation and
circulating levels of angiogenic cells. Circulating angiogenic
cells have been shown to participate in vascular repair and
regeneration.21–24 These cells are mobilized from the bone
marrow into the circulation by cytokines, growth factors, and
hormones and have been found to play an important role in
maintaining vascular health. Several observational studies
show a robust inverse association between circulating angiogenic cell levels and CVD risk25–27 and severity.28–31 In a prospective analysis, the levels of these cells were found to be
predictive of CVD mortality.32 We have previously reported
that acute exposure to elevated levels of ambient PM2.5
decreases the levels of these cells in circulation.33 However,
the effect of exposure to traffic pollution on the levels of circulating angiogenic cells has not been assessed. Thus, the main
objective of our study was to determine whether residential
proximity to a roadway affects the levels of angiogenic cells
in peripheral blood as a measure of CVD risk and whether this
effect is related to changes in systemic inflammation because
of roadway proximity.

is shown in the Figure (the residences presented are geographically masked). Study participants were concentrated in the
northwestern region of Jefferson County also known as West
Louisville. The Louisville Metro Department of Public Health
and Wellness reports that this area has disproportionately high
rates of CVD and high levels of air pollution.34,35 This area
also has a higher concentration of major roadways than other
geographic locations in Jefferson County, aside from the central business district.

Participant Characteristics
Adult participants with moderate-to-high CVD risk were
recruited between October 2009 and May 2013 from the
University of Louisville Hospital and affiliated clinic system. Participants from this cohort were middle aged (50±10
years), with a slightly higher proportion of men (n=162; 51%)
and whites (n=179; 58%; Table 1). A high percentage of the
population was comprised of current (n=109; 35%) or former
(n=91; 29%) smokers. A majority of the cohort was diagnosed
with hypertension (n=220; 71%), hyperlipidemia (n=187;
60%), and obesity (body mass index, ≥30; n=183; 59%).
Several participants were being treated with angiotensin-converting enzyme inhibitors (n=155; 50%), β-blockers (n=157;
50%), or statins (n=149; 48%). Of the 345 subjects, 316 (92%)
were successfully geocoded. Patients without a valid address
could not be geocoded and were not included in the study.

Demographic Comparison
Demographic characteristics of study participants living
within 50 m of a major roadway (roadway carrying a mean of
at least 5000 vehicles per day) or >50 m from a major roadway
are shown in Table 1. These two groups do not differ in age,
sex, ethnicity, hypertension, hyperlipidemia, diabetes mellitus, obesity, environmental tobacco smoke exposure, empirical smoke exposure (cotinine), medical history, medication

Materials and Methods
Materials and Methods are available in the online-only Data
Supplement.

Results
Geographic Distribution
Participant addresses were geocoded using data obtained from
the Louisville/Jefferson County Information Consortium composite locator via ArcMap 9.3+ geographic information system software. The geographic distribution of the participants

Figure. Patients’ residential locations in Jefferson County, KY.
Each dot represents the residential location of a single subject.
Residential locations are geographically masked to preserve
subject confidentiality, although general trends in subject distribution throughout the county are maintained. A major roadway
is defined as a roadway with an annual mean traffic volume of
>5000 vehicles per day.
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Table 1. Demographics and Medical History of the Study Population Stratified by Major Roadway Proximity
Total, n=316

<50 m, n=57 (%)

≥50 m, n=259 (%)

P Value

0.662

Categorical variable, n (%)
 Sex
  Female

154 (49)

26 (46)

128 (49)

  Male

162 (51)

31 (54)

131 (51)

 Ethnicity
  White

179 (58)

27 (51)

152 (60)

  Black

121 (40)

26 (49)

95 (37)

7 (2)

0 (0)

7 (3)

  Hispanic

0.168

 CVD risk factors
  Hypertension

220 (71)

36 (63)

184 (72)

0.199

  Hyperlipidemia

187 (60)

33 (58)

154 (61)

0.765

99 (32)

17 (30)

82 (32)

0.875

  Diabetes mellitus
  Obese (BMI, ≥30)

183 (59)

34 (61)

149 (59)

0.881

  Current smoker (self-report)

109 (35)

27 (47)

82 (32)

0.031

  Never smoked (self-report)

114 (36)

14 (25)

100 (39)

0.048

  Former smoker (self-report)

91 (29)

16 (28)

75 (29)

1.000

191 (63)

32 (57)

159 (64)

0.360

  Myocardial infarction

88 (28)

16 (28)

72 (28)

1.000

  Stroke

26 (8)

7 (12)

19 (7)

0.284

  CABG/PCI/stents

70 (22)

13 (23)

57 (22)

1.000

  Heart failure

46 (15)

6 (11)

40 (16)

0.529

6 (2)

2 (4)

4 (2)

0.296

155 (50)

30 (53)

125 (49)

0.662

18 (6)

2 (4)

16 (6)

0.544

157 (50)

29 (51)

128 (50)

1.000

65 (21)

12 (21)

53 (21)

1.000

  High CVD risk category*
 Medical history

  Cancer
Downloaded from http://ahajournals.org by on March 16, 2022

 Medication
  Angiotensin-converting enzyme inhibitor
  Angiotensin-receptor blockers
  β-Blocker
  Calcium-channel blockers
  Diuretics

118 (38)

21 (37)

97 (38)

1.000

  Statins

149 (48)

24 (42)

125 (49)

0.381

  Aspirin

157 (50)

30 (53)

127 (50)

0.770
0.652

Continuous variable, mean±SD
50±10

49±9

50±11

 Cotinine, μg/g of creatinine

 Age, y

520±1133

555±985

512±1163

0.374

 Creatinine, mg/dL

138±94

137±73

139±99

0.534

4.6±4.7

4.9±5.0

4.5±4.6

0.429

 Inflammation
  hsCRP, mg/L
 CVD risk
  Framingham Risk Score

6.6±.7.6

6.8±11.6

6.5±.5±

0.150

  Sum of CVD risk factors†

3.3±1.4

3.5±1.5

3.3±1.3

0.332

  Median household income,‡ ×103
  PM2.5, µg/m3

33±19

23±14

35±20

<0.001

13.1±5.6

13.3±5.5

13.0±5.6

0.756

Major roadways were defined as roads carrying an annual mean of ≥5000 vehicles per day. Major roadway proximity was calculated
as a straight line distance from the residential address of the subject to the nearest major roadway using geographic information system
technology. Cotinine was measured in the urine by gas chromatography-mass spectrometry analysis, urinary creatinine was measured
using a Cobas Mira Autoanalyzer, and hsCRP was measured using the VITROS kit as described before.58 BMI indicates body mass index;
CABG, coronary artery bypass graft; CVD, cardiovascular disease; hsCRP, high sensitivity C-reactive protein; PCI, percutaneous coronary
intervention; and PM2.5, fine particulate matter with an aerodynamic diameter ≤2.5 μm.
*Individuals with high CVD risk category had a Framingham Risk Score of ≥20 or had previously experienced a cardiovascular event.
†The sum of CVD risk factors includes the following Framingham risk factors: age ≥ 40 y, male sex, current smoker, hypertension,
hyperlipidemia, and diabetes mellitus.
‡Median household income is reported in USD at the US Census block group level.
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Table 2. Comparison of Circulating Angiogenic Cell Levels Stratified by Roadway Proximity
Circulating Angiogenic Cell Type*

<50 m, Mean±SD

≥50 m, Mean±SD

P Value
0.209

Cell type 1 (CD31 /34 /45 )

1.07±1.07

0.94±1.07

Cell type 2 (CD31+/34+/45+)

0.11±0.20

0.23±1.82

0.929

Cell type 3 (CD31+/34+/45dim/AC133+)

0.63±0.71

0.51±0.64

0.198

Cell type 4 (CD31+/34+/45+/AC133+)

0.02±0.03

0.02±0.06

0.478

Cell type 5 (CD31 /AC133 )

3.25±3.92

1.98±4.03

0.002

Cell type 6 (CD31+/34+)

1.50±1.48

1.69±3.83

0.621

Cell type 7 (CD31+/34+/45dim/AC133–)

0.44±0.52

0.42±0.71

0.886

Cell type 8 (CD31+/34+/45+/AC133–)

0.09±0.18

0.21±1.80

0.943

+

+

+

dim

+

Cell type 9 (CD34 )

1.59±1.53

1.87±4.58

0.621

Cell type 10 (CD31+)

280±204

255±231

0.291

Cell type 11 (AC133+)

4.24±4.73

2.86±5.02

0.006

Cell type 12 (CD45+)

695±647

615±633

0.321

+

Cell type 13 (CD34 /AC133 )

0.72±0.75

0.56±0.69

0.049

Cell type 14 (CD34+/45+/AC133+)

0.02±0.04

0.03±0.10

0.306

Cell type 15 (CD34+/45dim/AC133+)

0.61±0.69

0.47±0.59

0.109

+

+

*Data show the number of circulating angiogenic cells per microliter of blood, determined by flow cytometry as
described in Materials and Methods in the online-only Data Supplement.
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use, lymphocyte count, inflammation, or the Framingham
Risk Score. Participants living within 50 m of a major roadway were more likely to self-report being a current smoker
(47% versus 32%; P=0.031) and less likely to report having
never smoked (25% versus 39%; P=0.048) than those living
>50 m from a major roadway. People living closer to roadways
also lived in areas with significantly lower median household
incomes ($23 204 versus $35 494; P<0.001). These income
levels were substantially lower than the median household
income of $46 298 for the entire Jefferson County, KY, from
2007 to 2011.36 There was no significant association between
ambient PM2.5 levels and roadway proximity.

Association Between Circulating Angiogenic
Cells and Distance to Roadway
To examine the influence of roadway proximity on circulating angiogenic cells, we first compared the levels of these
cells in the peripheral blood of individuals living within 50
m of a major roadway with the levels of these cells in the

peripheral blood of those living >50 m from a major roadway estimated using the straight line distance to the nearest
major roadway. The results of these unadjusted t test analyses
are shown in Table 2. Of the 15 types of circulating angiogenic cell subpopulations examined, the levels of cell type 5
(CD31+/AC133+; P=0.002), cell type 11 (AC133+; P=0.006),
and cell type 13 (CD34+/AC133+; P=0.049) were significantly
and inversely associated with distance to roadway, that is,
the levels of these circulating angiogenic cells were higher
in people living closer to a major roadway. Cell types 5 and
11 remained significantly associated after adjustment for multiple comparisons (P=0.026 and P=0.039, respectively). No
associations were observed with other circulating angiogenic
cell subpopulations.
To examine the influence of potential confounders,
adjusted regression analyses were completed using generalized linear models. These regressions describe the association between circulating angiogenic cell levels and roadway
proximity and were adjusted for potential confounders: age,

Table 3. Association Between Major Roadway Proximity and Circulating
Angiogenic Cell Levels
Change (%)

95% CI

P Value

Cell type 4 (CD31+/34+/45+/AC133+)

Circulating Angiogenic Cell Type

−13.6

−49.5 to 48.0

0.595
0.008*

Cell type 5 (CD31 /AC133 )

−39.5

−58.2 to −12.4

Cell type 11 (AC133+)

−40.6

−60.0 to −11.7

0.010*

Cell type 13 (CD34+/AC133+)

−34.2

−54.7 to −4.33

0.028*

Cell type 14 (CD34+/45+/AC133+)

−17.8

−57.4 to 58.9

0.560

Cell type 15 (CD34 /45 /AC133 )

−32.5

−54.2 to −0.67

0.046*

+

+

+

dim

+

Participants were dichotomized by distance into those living <50 m, which was compared
with those living >50 m from a major roadway. Associations are corrected for age, sex,
ethnicity, body mass index, cigarette smoking, median household income, diabetes mellitus,
myocardial infarction, and PM2.5. CI indicates confidence interval; and PM2.5, fine particulate
matter with an aerodynamic diameter ≤2.5 μm.
*P<0.05.
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Table 4. Association Between Total Distance of Major Road Segments
and Circulating Angiogenic Cell Levels
Change (%)

95% CI

Cell type 4 (CD31+/34+/45+/AC133+)

Circulating Angiogenic Cell Type

2.04

−4.16 to 8.28

P Value
0.519

Cell type 5 (CD31+/AC133+)

5.82

1.25 to 10.4

0.013*

Cell type 11 (AC133+)

5.86

0.96 to 10.8

0.019*

Cell type 13 (CD34+/AC133+)

4.60

0.01 to 9.20

0.049*

Cell type 14 (CD34+/45+/AC133+)

2.31

−5.00 to 9.67

0.537

Cell type 15 (CD34 /45 /AC133 )

4.25

−0.50 to 9.00

0.079

+

dim

+

Percent change in cell populations per 10-m increase in major road distance within a 50-m
radius of an individual’s residence. Associations are adjusted for age, sex, ethnicity, body mass
index, socioeconomic status, cigarette smoking, diabetes mellitus, myocardial infarction, and
PM2.5. CI indicates confidence interval; and PM2.5, fine particulate matter with an aerodynamic
diameter ≤2.5 μm.
*P<0.05.
†P<0.05 for the population with 6-month residential duration.
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sex, ethnicity, body mass index, cigarette smoking, median
household income, myocardial infarction, diabetes mellitus,
and 24-hour PM2.5. Patients with cancer (n=6) were excluded
from all adjusted regression analyses. After adjustment, the
levels of cell type 5 (P=0.008), cell type 11 (P=0.010), cell
type 13 (P=0.028), and cell type 15 (CD34+/45dim/AC133+;
P=0.046) were significantly associated with distance to roadway (Table 3). The levels of these cells in peripheral blood
were higher in individuals living within 50 m of a major roadway. Specifically, the levels of cell types 5, 11, 13, and 15
were greater by 40%, 41%, 34%, and 32%, respectively, in the
population living closer to a major roadway.

Association of Circulating Angiogenic Cell
Levels and Cumulative Major Road Segments
Although living within 50 m of the nearest major roadway
showed significant association with specific angiogenic cell
populations, the total exposure to roadways could be affected
by the presence of other major roadways in close proximity
to the residence. Hence, we examined how exposure to all
surrounding major roads near the residence would influence
circulating angiogenic cell levels. For this, all major road
segments within a circular 50-m radius buffer zone around
subjects’ residences were combined to obtain cumulative

road segments within the buffer zone. The results from the
adjusted generalized linear model of the relationship between
circulating angiogenic cells and cumulative major road segments are shown in Table 4. After adjustment, cell type 5
(P=0.013), cell type 11 (P=0.019), and cell type 13 (P=0.049)
were significantly associated with the cumulative distance of
each roadway segment within 50 m of the residence. These
results indicate that as the total distance of major road segments increases within a 50-m buffer, the levels of these specific circulating angiogenic cells also increase. Each meter of
major roadway within the 50-m buffer was associated with a
0.6% increase in cell types 5 and 11 and a 0.5% increase in
cell type 13. Importantly, when expanded to all road segments
within a 50-m buffer, none of these cell populations remained
associated with cumulative road segment distances. These
data support the notion that the levels of specific circulating
angiogenic cells are associated with residential distance from
a major roadway and not background exposures.

Association of Circulating Angiogenic Cell
Levels and Major Road Segment Intensity
To build on the notion that the sum of road segments in close
residential proximity is associated with circulating angiogenic
cell levels, we investigated whether traffic concentration on

Table 5. Association Between Major Road Segment Intensity and Circulating
Angiogenic Cell Levels
Circulating Angiogenic Cell Type

Change (%)

95% CI

P Value

−13.0

−74.7 to 48.6

0.679

Cell type 5 (CD31 /AC133 )

41.4

3.70 to 79.2

0.032*

Cell type 11 (AC133+)

46.7

6.50 to 86.9

0.023*

Cell type 13 (CD34+/AC133+)

34.0

−2.90 to 70.9

0.071

Cell type 14 (CD34+/45+/AC133+)

−9.10

−78.5 to 60.2

0.796

Cell type 15 (CD34 /45 /AC133 )

32.4

−5.10 to 70.0

0.091

Cell type 4 (CD31+/34+/45+/AC133+)
+

+

+

dim

+

Percent change in cell populations per 1-km increase in total vehicle distance traveled within a 50-m
radius of individual’s residence. Associations are adjusted for age, sex, ethnicity, body mass index,
socioeconomic status, cigarette smoking, diabetes mellitus, myocardial infarction, and PM2.5. CI indicates
confidence interval; and PM2.5, fine particulate matter with an aerodynamic diameter ≤2.5 μm.
*P<0.05.
†P<0.05 for the population with 6-month residential duration.
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Table 6. Association Between Circulating Angiogenic Cell Levels and
Distance-Weighted Roadway Traffic Intensity
Circulating Angiogenic Cell Type

Change (%)

95% CI

P Value

Cell type 4 (CD31+/34+/45+/AC133+)

3.69

0.16 to 7.23

0.040*†

Cell type 5 (CD31+/AC133+)

0.66

−2.49 to 3.81

0.682

Cell type 11 (AC133 )

0.16

−3.24 to 3.57

0.927

Cell type 13 (CD34+/AC133+)

0.63

−2.38 to 3.64

0.683

Cell type 14 (CD34+/45+/AC133+)

2.66

−1.18 to 6.52

0.175

Cell type 15 (CD34 /45 /AC133 )

0.38

−2.71 to 3.49

0.808

+

+

dim

+

Percent change in cell populations per 10-m (weighted by distance to roadway) increase in
total vehicle distance travelled within a 300-m radius of individual’s residence. Associations are
adjusted for age, sex, ethnicity, body mass index, cigarette smoking, median household income,
diabetes mellitus, myocardial infarction, and PM2.5. CI indicates confidence interval; and PM2.5, fine
particulate matter with an aerodynamic diameter ≤2.5 μm.
*P<0.05.
†P<0.05 for the population with 6-month residential duration.
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these road segments influences this association. For this, we
calculated roadway traffic intensity as the daily sum of vehicle
distance travelled on the major road segments within 50 m of
the participant’s address. We found that cell type 5 (P=0.032)
and cell type 11 (P=0.023) were positively associated with
traffic intensity. These results suggest that as the traffic intensity increases within a 50-m buffer, there is an increase in
the levels of cell types 5 and 11(Table 5). Quantitatively, this
analysis indicates that for each kilometer traveled within the
buffer, there was a 0.04% increase in cell type 5 and a 0.05%
increase in cell type 11.

Association of Circulating Angiogenic Cell Levels
and Distance-Weighted Traffic Intensity
To examine exposure measures in greater detail, we calculated
major roadway vehicle traffic intensity weighted for distance
to those roadways. These values were generated on a continuous raster surface at 10-m resolution and extracted by address
points. A cutoff value of 300 m from major roads was selected
because it is the distance at which most pollutants reach background levels.37 After adjustment, cell type 4 (CD31+/34+/45+/
AC133+; P=0.040) was significantly associated with distanceweighted roadway traffic intensity. For each 10-m increase
in the value of weighted roadway intensity, there was a 4%
increase in cell type 4 (Table 6). This association remained
consistent within the population with 6-month residential
duration (P=0.011), corresponding to a 0.6% increase in cell
type 4 for each unit increase in roadway density.

Adjusted Association of Circulating
Angiogenic Cell Levels and PM2.5

Ambient levels of PM2.5 were estimated by calculating
the 24-hour average of all regional environmental protection agency–validated monitoring stations within 30 km of
Jefferson County, KY, that report daily PM2.5 levels.38 Our
analysis identified a significant association between circulating angiogenic cells and ambient PM2.5 in the 24-hour proceeding enrollment in the total population, where the levels
of cell type 3 (CD31+/34+/45dim/AC133+; P=0.037), cell type
4 (P=0.001), cell type 14 (CD34+/45+/AC133+; P<0.001), and

cell type 15 (P=0.032) were inversely associated with ambient PM2.5 after adjusting for age, sex, ethnicity, body mass
index, cigarette smoking, median household income, myocardial infarction, and diabetes mellitus (Table 7). Cell types
4 and 14 remained significantly associated after adjustment
for multiple comparisons in the total population (P=0.007
and P=0.002, respectively). These observations indicate that
circulating angiogenic cell levels are inversely related to the
levels of ambient 24-hour PM2.5 levels and that each 10-µg/m3
increase of PM2.5 was associated with a 62% decrease in cell
type 4 and an 81% decrease in cell type 14. The levels of cell
types 5, 11, and 13, however, were not associated with PM2.5
levels. Similar associations were observed when the dichotomous distance to major roadway variable was included in
the model (data not shown). No significant association was
observed between PM2.5 levels and roadway proximity. Cell
types 4 and 14 also remained significantly associated in the
population with 6-month residential duration (P=0.007 and
P<0.001, respectively) and after adjustment for multiple
comparisons within that population (P=0.049 and P=0.005,
respectively). Collectively, these data suggest that exposure to
increased ambient PM2.5 is associated with a decrease in the
levels of circulating angiogenic cell levels. Although roadway
proximity and PM2.5 affect similar circulating angiogenic cell
subpopulations, their effects are opposite to one another.

Discussion
The major finding of this study is that residential proximity
to major roadways is associated with a selective increase in
the levels of circulating angiogenic cells that are positive for
AC133, an antigen that indicates an immature cell, early in the
process of differentiation. The results obtained were similar
when exposure was estimated using either as a straight line
distance to major roadway, the sum of roadways in a 50-m
buffer, traffic intensity within a 50-m buffer, or the distanceweighted roadway traffic density within a 300-m buffer.
However, no association was observed between residential
proximity to major roadways and the inflammatory marker
high-sensitivity C-reactive protein, suggesting that changes
in circulating angiogenic cell levels are unlikely to be driven
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Table 7. Association Between 24-h PM2.5 and Circulating Angiogenic Cell
Levels
Circulating Angiogenic Cell Type

Change (%)

95% CI

P Value

Cell type 3 (CD31+/34+/45dim/AC133+)

−27.6

−52.1 to −1.68

0.037*

Cell type 4 (CD31+/34+/45+/AC133+)

−62.0

−95.5 to −26.5

0.001*†

Cell type 5 (CD31 /AC133 )

20.2

−4.91 to 45.5

0.117

Cell type 11 (AC133+)

−2.00

−27.7 to 24.2

0.875

+

+

Cell type 13 (CD34+/AC133+)

−23.7

−48.1 to 0.84

0.058

Cell type 14 (CD34+/45+/AC133+)

−81.5

−122 to −40.0

<0.001*†

Cell type 15 (CD34+/45dim/AC133+)

−27.6

−52.8 to −2.44

0.032*

Percent change in cell populations per 10-µg/m3 increase in regional PM2.5 on the day
before enrollment. CI indicates confidence interval; and PM2.5, fine particulate matter with an
aerodynamic diameter ≤2.5 μm.
*P<0.05.
†P<0.05 for population with 6-month residential duration.
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significantly by an increase in systemic inflammation. Thus,
regardless of other concurrent changes, our results suggest
that the levels of angiogenic cells in peripheral blood may be
useful biomarkers of cardiovascular injury associated with
residential proximity to roadways or traffic exposure.
In the cohort examined, we found that the CVD risk in the
individuals living closer than 50 m to major roadways was not
higher than that in those living >50 m from a major roadway;
therefore, the relationship between roadway proximity and
circulating angiogenic cell levels could not be attributed to
increased CVD risk. Moreover, it has been previously shown
that higher CVD risk in individuals with stable CVD is associated with a decrease rather than an increase in circulating
angiogenic cell levels.39 Thus, higher circulating angiogenic
cell levels in individuals living next to major roadways seem
to contribute to CVD risk not reflected by traditional CVD risk
factors. Also, the effect of roadway proximity on circulating
angiogenic cells could not be attributed to the effects of ambient
PM2.5 exposure because the relationship was not affected after
adjusting for ambient PM2.5 levels. That the effects of roadway
proximity are distinct from those of ambient fine PM is further
supported by the observation that, despite a decrease in circulating angiogenic cell levels related to ambient PM2.5 exposure,
residential roadway proximity was associated with an increase
in AC133+ progenitor cell levels. Moreover, the effects of PM2.5
were predominant on cell types 4 and 14, whereas roadway
proximity affected cell types 5, 11, 13, and 15. Although both
these populations include CD34+ and AC133+ cells, cell populations affected by PM2.5 were CD45+, whereas roadway proximity affected the entire population of AC133+ or CD34+ cells
that were either CD45+ or CD45− or those that were CD45dim
(cell type 15). These findings suggest that roadway proximity and ambient PM2.5 levels affect different cell populations
and that PM2.5 selectively affects cells retaining hematopoietic
characteristics, whereas roadway proximity has greater effects
on immature AC133+ progenitor cells.
Previous work has shown that the reduced number of circulating angiogenic cells is associated with increased CVD
risk and that the lower levels of these cells in peripheral blood
predict future cardiovascular events.40 Likewise, chronic exposures to environmental pollutants, such as PM2.5 (Table 7)
or tobacco smoke, are also associated with a decrease in the

circulating levels of these cells.41 In contrast to these findings,
we found higher levels of these cells in individuals living close
to a major roadway. Reasons for the anomalous increase in the
levels of these cells because of roadway exposure are not clear
but may be related to the milder nature of the injury induced by
roadway pollutants compared with other insults. Increased levels of angiogenic cells in response to roadway pollutant exposure may be reflective of continuous mobilization of these cells
from the bone marrow to peripheral blood, without the suppressive effects of stronger insults. In our previous work, we
have found that exposure to the highly toxic pollutant acrolein
leads to a 3- to 4-fold increase in the population of angiogenic
cells in the bone marrow in mice, but the levels of these cells
in circulation are decreased (by 40%) because mobilization of
these cells is prevented due to a concurrent defect in vascular
endothelial growth factor-1 and stromal cell–derived factor-1
signaling.42 Our studies also show that exposure to concentrated PM2.5 increases the bone marrow abundance of angiogenic cells in mice, although the circulating levels of these
cells are decreased because of a selective defect in their mobilization by vascular endothelial growth factor and stromal cell–
derived factor-1 but not stem cell factor. Indeed, in response
to stem cell factor, more cells are recruited in the blood in
PM2.5-exposed mice than in mice exposed to filtered air.43 On
the basis of these observations, we speculate that, like acrolein
and PM2.5, roadway pollutant exposure increases the production of angiogenic cells in the bone marrow, but because there
are no additional suppressive effects on mobilization, the levels of these cells are increased in the peripheral blood as well.
Although further studies are required to test this hypothesis,
elevated levels of angiogenic cells in the blood of individuals
living close to a major roadway are consistent with the presence of mild and persistent vascular injury in these individuals.
Vascular injury secondary to burns or coronary artery
bypass or myocardial infraction has been shown to be associated with an acute increase in circulating levels of angiogenic
cells.44,45 Exposure to secondhand smoke is also associated
with increased levels of angiogenic cells in the peripheral
blood 24 hours post exposure.46 Thus, acute vascular injury
seems to be a potent signal for the proliferation and mobilization of these cells particularly in individuals, such as those
in our cohort with preexisting CVD and high CVD risk. In
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addition, chronic insults, such as persistent tissue hypoxia,
inflammation, or demand for tissue repair, could also lead to
a persistent increase in the circulating levels of these cells.
Several clinical studies have shown that the levels of these
cells are chronically elevated in patients with cancer and that
higher levels of these cells correlate with angiogenesis, metastases, and reduced patient survival.47,48 Although all known
cases of cancer were excluded from our analysis, chronically
elevated levels of angiogenic cells in the blood of individuals
living next to major roadways could be a symptom of incipient
tumors, inflammation or tissue hypoxia, or ongoing vascular
injury, conditions that lead to a persistent increase in the circulating levels of angiogenic cells, especially when the insult is
mild and does not overwhelm mobilization. We found that in
individuals living <50 m of a major roadway, the levels of these
cells were 48% to 65% higher when compared with those living >50 m from a major roadway. In comparison, individuals
exposed to secondhand smoke show a 100% to 310% increase
in these cells, whereas myocardial infarction is associated with
a 213% to 900%; and coronary artery bypass grafting with a
26- to 50-fold increase in the levels of circulating angiogenic
cells.44,46,49 The levels of these cells are chronically elevated 2to 16-fold in patients with cancer in comparison with healthy
controls.48 Thus, in comparison with other insults, the effects
of roadway pollutant seem to be less severe and are likely to be
reflective of subclinical vascular injury resulting in increased
angiogenic cell mobilization from the bone marrow.
When first mobilized from the bone marrow, the circulating angiogenic cells are mostly AC133+, an indicator of their
immature, early state in the process of differentiation. As these
cells mature and differentiate, however, these cells lose AC133+
expression.23,24 The early AC133+ cells also express the inhibitor of DNA binding, which is a robust indicator of the endothelial progenitor phenotype.50–52 Thus, the selective increase in
AC133+ cells observed in our study cohort is consistent with
a scenario wherein bone marrow activation leads to increased
mobilization of immature angiogenic cells into peripheral blood
to promote endothelial repair or regeneration. In contrast, we
found no significant association between proximity to a major
roadway and high-sensitivity C-reactive protein, suggesting that
this was not because of generalized systemic inflammation in
this cohort. Nevertheless, further work is required to assess any
contribution of inflammation to cardiovascular injury induced
by proximity to roadways and how this might be related to the
overall increase in disease risk and mortality.
A major strength of our investigation is the relatively large
study population combined with simultaneous measurements
of conventional and novel CVD risk factors. Although, in
comparison with environmental epidemiological studies, this
size of the study population may seem small, most epidemiological studies use population level data, whereas our study
is primarily based on individual level data. To the best of our
knowledge, our study includes the largest number of circulating angiogenic cell phenotypes assessed to date. The range
of CVD risk factors within our study population makes it a
diverse group in which to investigate susceptibility to such
roadway exposures, which may have had a lesser effect on a
young healthy population. In addition, we measured a large

number of phenotypically distinct circulating angiogenic cell
populations to understand which specific populations were
sensitive to residential roadway proximity. Accounting for
potential major confounders, such as the levels of cotinine,
a urine nicotine metabolite, in addition to collecting data on
self-reported smoking status, did not alter the relationship
with roadway proximity. Patients with cancer were excluded
from the final regression analyses because circulating angiogenic cells are recruited in tumor angiogenesis,50–52 which
may disproportionally increase circulating angiogenic cell
levels. Multiple indices of roadway exposure were included
in this analysis to obtain a better assessment of traffic-related
exposure, including variables of dichotomous 50-m roadway proximity, continuous sum of road segments in a 50-m
buffer, continuous traffic intensity, and continuous distanceweighted roadway intensity in a 300-m buffer. Although it is
a strength that we adjusted for multiple comparisons, results
from this adjustment, however, should be interpreted with
caution because multiple correction adjustments are not recommended for highly correlated variables,53 as is the case
with the circulating angiogenic cell populations in the current
investigation.
Our study has several limitations. An important limitation is that we did not measure traffic noise, which has been
associated with higher blood pressure54 and increased risk
of adverse cardiovascular outcomes.55,56 Noise is associated
with distance to roadway, and thus, it could be related to
our outcomes. In addition, land use and tree cover, factors
that can mediate or exacerbate the effects of traffic pollution
exposure, were not measured in this study. Also, the use of
road proximity as an indicator of exposure to traffic pollutants
assumes that the study participants spend much of their time
at home, and therefore, it does not account for the duration
of time individuals spent outside their home, the proximity to
roadways during other activities, or indoor exposures in the
home. There was also no accounting for time spent in vehicles or in traffic, which has been associated with increased
CVD risk.57 Because our cohort comprised of individuals
with high CVD risk, results obtained from this cohort may
not be readily extrapolated to a general population of healthy
individuals. Finally, because of the cross-sectional design
of the study, causality could not be established. Long-term
prospective studies are required to examine how recurrent
exposure to traffic pollution affects circulating angiogenic
cell levels and whether changes in their levels correspond
to greater progression of CVD in individuals who live near
major roadways.
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Significance
The results of this study show that residential proximity to major roadways is associated with an increase in the levels of AC133+ circulating
angiogenic cell levels. This finding suggest that recurrent exposure to traffic could induce cardiac injury resulting in greater recruitment of
premature angiogenic cells into the circulation. We found that the relationship between residential proximity to roadways and AC133+ cells
was not confounded by smoking, sex, or socioeconomic status and was not associated with concurrent changes in thrombosis, fibrinogen,
or the levels of the inflammatory marker high-sensitivity C-reactive protein. The observed increase in these cells likely reflects an important
mechanism that imparts excessive cardiovascular disease risk (perhaps independent of traditional risk factors) in individuals repeatedly
exposed to traffic pollutants (eg, volatile organic compounds, particulate matter, and noise).

